S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Log in

CareTrust REIT Price Target, Predictions & Analyst Ratings

+0.03 (+0.13 %)
(As of 01/21/2021 12:00 AM ET)
Today's Range
Now: $22.71
50-Day Range
MA: $22.20
52-Week Range
Now: $22.71
Volume417,391 shs
Average Volume664,718 shs
Market Capitalization$2.17 billion
P/E Ratio26.72
Dividend Yield4.41%

Analyst Ratings

CareTrust REIT (NASDAQ:CTRE) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
9 Wall Street analysts have issued ratings and price targets for CareTrust REIT in the last 12 months. Their average twelve-month price target is $23.11, predicting that the stock has a possible upside of 1.77%. The high price target for CTRE is $26.00 and the low price target for CTRE is $21.00. There are currently 1 hold rating, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
CTRE Consensus Rating: BuyBuyBuyBuy
CTRE Consensus Rating Score: 3.002.882.672.57
CTRE Analyst Ratings: 0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
CTRE Consensus Price Target: $23.11$22.00$21.67$21.43
CTRE Price Target Upside: 1.77% upside11.10% upside10.49% upside9.84% upside

CareTrust REIT (NASDAQ:CTRE) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CareTrust REIT (NASDAQ:CTRE) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/19/2021BarclaysBoost Price TargetOverweight$21.00 ➝ $25.00Low
1/13/2021MizuhoBoost Price TargetNeutral$19.00 ➝ $22.00Low
1/7/2021BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$25.00 ➝ $26.00Medium
12/14/2020KeyCorpUpgradeSector Weight ➝ Overweight$24.00Low
12/2/2020Berenberg BankUpgradeHold ➝ BuyLow
11/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$20.00 ➝ $22.00Low
9/1/2020Stifel NicolausReiterated RatingBuy$22.00High
8/10/2020Raymond JamesBoost Price TargetStrong-Buy$21.00 ➝ $22.00Medium
6/17/2020Wells Fargo & CompanyBoost Price TargetOverweight$20.00 ➝ $21.00Low
8/21/2019Capital One FinancialUpgradeEqual Weight ➝ Overweight$25.00Low
11/5/2018Cantor FitzgeraldReiterated RatingBuy$20.00High
(Data available from 1/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.